Furthermore, we find that MKK3/p38γ/δ hyperactivation in MKK6 KO mice promotes cardiac hypertrophy through mTOR activation, which progresses to a pathological cardiac hypertrophy phenotype with age and development of cardiac dysfunction. Here, MAP2K6 is linked to cardiac hypertrophy.